In summary, the discovery of the interaction between the Alzheimer’s disease-related protein PS1 and the major glutamate transporter (GLT-1) may provide a missing link between the amyloid pathology and aberrant glutamate transport in AD. The gene discussed is SLC1A2; the disease is glycogen storage disease VI.